About Thrive Bioscience
Thrive Bioscience is a company based in Boston (United States) founded in 2014 by Thomas Forest Farb. Thrive Bioscience has raised $15.13 million across 4 funding rounds from investors including Triple Ring Technologies, Life Science Angels and SideCar Angels. Thrive Bioscience operates in a competitive market with competitors including 10X Genomics, MaxCyte, Mission Bio, SQZBiotech and Cellares, among others.
- Headquarter Boston, United States
- Founders Thomas Forest Farb
- SectorsHealthcare
- Website thrivebio.com
- Social LinkedIn
- Total Equity Funding$15.13M (USD)
in 4 rounds
- Latest Funding Round$1.8M (USD), Series A
Aug 2017
- InvestorsTriple Ring Technologies
& 3 more
Funding Insights of Thrive Bioscience
Thrive Bioscience has successfully raised a total of $15.13M across 4 strategic funding rounds. The most recent funding activity was a Series A round of $1.8 million completed in August 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $15.13M
- Total Rounds 4
- Last Round Series A — $1.8M
- First Round $4M
(May 2015)
- Investors Count 4
All 4 funding rounds of Thrive Bioscience with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2017 | $1.8M | Series A | – | – | – |
| Mar 2017 | $7.15M | Series A | – | – | – |
| Dec 2015 | $2.18M | Seed | – | – | – |
| May 2015 | $4M | Seed | – | – |
4 investors in total: 4 institutional.
Investors in Thrive Bioscience
Thrive Bioscience has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Triple Ring Technologies, Life Science Angels and SideCar Angels.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Life sciences startups are funded by a non-profit angel network. | – | lifescienceangels.com | Sunnyvale, United States | |
Angel investments are facilitated for Boston-based companies via sidecar models. | – | sidecarangels.com | Cambridge, United States | |
Startups are incubated across diverse sectors by Triple Ring Technologies. | 2004 | tripleringtech.com | Newark, United States | |
Optikos is engaged in optical engineering and metrology solutions. | – | optikos.com | Wakefield, USA |
Investor details for Thrive Bioscience
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Thrive Bioscience
1 people are tracked at Thrive Bioscience (1 in leadership).
| Name | Role | Group |
|---|---|---|
Thomas Forest Farb | Co-Founder & COO, President | Leadership |
Complete people profiles for Thrive Bioscience
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Thrive Bioscience
3 dated milestones of Thrive Bioscience across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Thrive Bioscience is founded.
- Funding First funding round of $4.0M.
- Funding Latest funding round, Series A, of $1.8M.
Competitors of Thrive Bioscience
Thrive Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as 10X Genomics, MaxCyte, Mission Bio, SQZBiotech and Cellares, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| 10xgenomics.com | 2012 | Pleasanton, United States | $199.9M | 961 | Instrument systems for genomic research and sequencing libraries are developed. | |
| maxcyte.com | 1998 | Gaithersburg, United States | $20.69M | 71 | Instrument systems for cell processing and modification are provided. | |
| missionbio.com | 2014 | San Francisco, United States | $110M | 109 | Single-cell multi-omics platform is provided for genotypic and phenotypic analysis. | |
| sqzbiotech.com | 2013 | Boston, United States | $167.41M | 117 | Cell therapies are developed using proprietary Cell Squeeze technology. | |
| cellares.com | 2019 | San Francisco, United States | $355M | – | Medical devices for cell-based therapy manufacturing are produced. | |
| lumicks.com | 2014 | Amsterdam, Netherlands | $93.38M | – | Optical tweezers instruments for single-molecule analysis are manufactured. | |
| geminibio.com | 1985 | West Sacramento, United States | $5.68M | 79 | Supplement reagents for cell and gene therapy are manufactured. | |
| levitasbio.com | 2017 | San Francisco, United States | $73.77M | – | Single-cell imaging platform developed via magnetic levitation technology. | |
| fluxionbio.com | 2005 | San Francisco, United States | $20.85M | – | Microfluidics-based tools for cellular analysis are provided. |
Detailed competitors of Thrive Bioscience
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Thrive Bioscience
The website of Thrive Bioscience (thrivebio.com) receives about 1.6K visits a month.
- Monthly visits1.6K
▼ 15.9% vs previous month
Latest news on Thrive Bioscience
Complete news archive for Thrive Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to Thrive Bioscience
10 companies that operate in the same segment as Thrive Bioscience (Genomics & Gene Therapy Platforms), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 2,020 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 3.22 B | USD 147.17 M | 1,000 | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Provider of genetic test solutions to study ancestry, genealogy, and inherited traits | 2006 | Sunnyvale, California, United States | USD 943.53 M | USD 189.9 M | 265 | |
Provider of DNA testing services to create a family tree and ancestor | 2003 | Yehud, Central District, Israel | USD 40 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Gene therapies for rare diseases including retinal dystrophies are developed. | 2013 | Philadelphia, Pennsylvania, United States | USD 82.8 M | USD 64.73 M | 822 | |
Therapeutics for genetic diseases are developed through targeted interventions. | 2015 | Palo Alto, California, United States | USD 434.2 M | USD 502.08 M | 730 | |
Provider of an online genealogy platform offering a host of services | 1996 | Lehi, Utah, United States | USD 146.2 M | – | – |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Thrive Bioscience
Thrive Bioscience was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Thrive Bioscience is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.
Thrive Bioscience is a funded company, having raised a total of $15.13M across 4 funding rounds to date. The company's 1st funding round was a Seed of $4M, raised on May 2015.
Thrive Bioscience is developing and commercializing a suite of automated, analytical, non-microbial cell culture systems to meet the needs of the large, cell-based research, drug discovery, drug development regenerative medicine markets. The product family is based on robotics, fluidics computational imaging. Its products include Cell Assayer (automating assays for drug discoverydevelopment basic research); Cell Maintainer (maintaining cells for disease modeling cell therapies), Cell Passager (growing cells as infrastructure).
Thrive Bioscience's top competitors include MaxCyte, 10X Genomics and Mission Bio.
Thrive Bioscience has 4 investors. Key investors include Triple Ring Technologies, Life Science Angels, SideCar Angels, and Optikos.